Delivery Order SPE2DB22D1103-SPE2DB22FE1FP
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568624673 RISPERDAL 4 MG TABLET 60S, with a ceiling value of $9,000.73 and a completion date of June 25, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERDAL 3 MG TABLET 60S, a prescription medication, with a firm fixed price of $1,004.68 and a completion date of July 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,909.23 and is for the delivery of 4567152495 - RISPERIDONE 2 MG TABLET 500S. It is a firm fixed-price contract that runs through February 5, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and there are no mentioned...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.38 firm-fixed-price contract is for the delivery of RISPERDAL 0.5 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4 mg Risperidone tablets, a medication commonly used to treat mental health conditions. The contract has a firm fixed price of $4,839.40 and a completion date of July 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor, and there is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 3 mg tablets. The contract has a ceiling value of $1,013.91 and a performance period through May 21, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 18, 2025, procures 60 tablets of Risperdal 2 mg with a ceiling value of $4,281.44. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency's Medical Supply Chain and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This award was competitively awarded with no set-aside designation and represents a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 2 mg tablets. The contract has a ceiling value of $7,756.45 and an ultimate completion date of May 8, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,757.21 firm fixed-price contract is for the supply of Risperidone 2 mg orally disintegrating tablets, a medication used to treat certain mental/mood disorders. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB22FE1FPDelivery Order
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of RISPERDAL 4 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type, a ceiling value of $5,693.81, and a period of performance through May 24, 2022. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a child contract under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 5/23/22 |